Loading…
Alterity Therapeutics Limited is projected to rise to $5.60 by 2027, a +27% move from its current price of $4.42. ATHE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.28 | $4.42 | $4.56 | +0.07% |
| Aug 6 | $4.22 | $4.42 | $4.63 | +0.13% |
| Aug 7 | $4.18 | $4.42 | $4.68 | +0.20% |
| Aug 8 | $4.15 | $4.43 | $4.72 | +0.27% |
| Aug 9 | $4.12 | $4.43 | $4.76 | +0.33% |
| Aug 10 | $4.10 | $4.43 | $4.80 | +0.40% |
| Aug 11 | $4.07 | $4.44 | $4.83 | +0.47% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.07 | $4.44 | $4.83 | +0.47% |
| Week 2 | $3.95 | $4.46 | $5.02 | +0.94% |
| Week 3 | $3.87 | $4.48 | $5.19 | +1.41% |
| Week 4 | $3.80 | $4.50 | $5.33 | +1.89% |
| Week 5 | $3.74 | $4.52 | $5.46 | +2.37% |
| Week 6 | $3.69 | $4.54 | $5.59 | +2.85% |
| Week 7 | $3.64 | $4.56 | $5.71 | +3.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alterity Therapeutics Limited engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease.
Its lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy.
The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.
Alterity Therapeutics Limited is a healthcare asset trading under symbol ATHE in the healthcare sector. Its current price is $4.54 and market capitalization is $82.29M. Rank: 4074.
The forecast path shows a progression in average price from 2026 onward, with 2026 avg $4.54 and 2027 avg $5.61, 2028 avg $7.02, 2029 avg $10.45, 2030 avg $11.62, 2040 avg $31.42, and 2050 avg $82.56. The associated ROIs rise from 0% in 2026 to 23.6% in 2027, 54.5% in 2028, 130.3% in 2029, 156.1% in 2030, 592% in 2040, and 1718.4% in 2050, with a bullish sentiment emerging in later years.
A major floor 28.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.1% away) — a key level to hold.
The nearest ceiling, 33.4% above — a clean break opens room to run.
A major ceiling 44.5% above — clearing it would confirm fresh momentum.
Key ATHE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATHE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.52 | Sell | $4.51 | Sell |
| MA 10 | $4.63 | Sell | $4.64 | Sell |
| MA 20 | $4.97 | Sell | $4.77 | Sell |
| MA 50 | $4.68 | Sell | $4.70 | Sell |
| MA 100 | $4.35 | Buy | $4.45 | Sell |
| MA 200 | $3.96 | Buy | $4.19 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.17 | Neutral |
| Stoch RSI (14) | 0.53 | Buy |
| CCI (20) | -105.60 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.09 | Sell |
| ROC (12) | -11.42 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.03 | Sell |
| Awesome (5,34) | -0.44 | Sell |
| Ultimate (7,14,28) | 30.27 | Neutral |
| Momentum (10) | -0.56 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 4.42 | Sell |
| ADX (14) | 16.29 | Neutral |
| ATR (14) | 0.14 | Info |
Market sentiment is BULLISH with RSI14 at 40. The 50-day and 200-day moving averages are $4.67 and $3.96 respectively. Support is at $4.11 and resistance at $5.89. The thirty-day price range spans from $3.58 to $5.76.
Annualized volatility is 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.02 | $4.42 | $6.27 | 0% | Neutral | |
| $4.39 | $5.60 | $7.58 | +27% | Bullish | |
| $5.18 | $6.83 | $9.66 | +55% | Bullish | |
| $7.48 | $10.13 | $14.81 | +129% | Bullish | |
| $8.24 | $11.45 | $17.22 | +159% | Bullish | |
| $8.59 | $12.22 | $18.82 | +177% | Bullish | |
| $9.83 | $14.27 | $22.46 | +223% | Bullish | |
| $9.75 | $14.43 | $23.17 | +227% | Bullish | |
| $10.97 | $16.55 | $27.05 | +275% | Bullish | |
| $13.34 | $20.50 | $34.07 | +364% | Bullish | |
| $19.02 | $31.78 | $56.58 | +620% | Bullish | |
| $43.76 | $84.71 | $166.69 | +18.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.02 | $4.42 | $5.62 | +0.00% |
| September 2026 | $4.01 | $4.76 | $5.84 | +7.88% |
| October 2026 | $3.92 | $4.69 | $5.82 | -1.48% |
| November 2026 | $3.98 | $4.81 | $6.02 | +2.42% |
| December 2026 | $4.08 | $4.95 | $6.27 | +3.05% |
Click any year to see its month-by-month ATHE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ATHE price prediction for 2026 points to an average of $4.42 (low $3.02, high $6.27) — a potential gain of 0% on today's $4.42. A consolidation phase looks the most probable path here.
In 2027, ATHE is projected to trade between $4.39 and $7.58, averaging $5.60 — a potential gain of +27% from today's $4.42. That is up +27% on the projected 2026 average. Momentum favours further upside here.
Alterity Therapeutics Limited's 2028 outlook centres on $6.83, within a $5.18 to $9.66 range. That is up +22% on the projected 2027 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, ATHE could reach as high as $14.81, with a base case around $10.13 and support toward $7.48 — roughly +129% from $4.42. Momentum favours further upside here.
Expect ATHE to range from $8.24 to $17.22 through 2030. The $11.45 average target implies a +159% move from current prices. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ATHE price prediction for 2031 points to an average of $12.22 (low $8.59, high $18.82) — a potential gain of +177% on today's $4.42. Momentum favours further upside here.
In 2032, ATHE is projected to trade between $9.83 and $22.46, averaging $14.27 — a potential gain of +223% from today's $4.42. That is up +17% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Alterity Therapeutics Limited's 2033 outlook centres on $14.43, within a $9.75 to $23.17 range. That is up +1% on the projected 2032 average. That marks a +227% change versus current levels. Momentum favours further upside here.
By 2034, ATHE could reach as high as $27.05, with a base case around $16.55 and support toward $10.97 — roughly +275% from $4.42. Buyers look set to stay in control over this stretch.
Expect ATHE to range from $13.34 to $34.07 through 2035. The $20.50 average target implies a +364% move from current prices. That is up +24% on the projected 2034 average. Momentum favours further upside here.
The ATHE price prediction for 2040 points to an average of $31.78 (low $19.02, high $56.58) — a potential gain of +620% on today's $4.42. Buyers look set to stay in control over this stretch.
In 2050, ATHE is projected to trade between $43.76 and $166.69, averaging $84.71 — a potential gain of +18.2x from today's $4.42. That is up +167% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ATHE today (≈ 226.500566 ATHE) could be worth
$19,187.34
+$18,187.34 (+1819%) by 2050 · US Dollar
Based on the average projected ATHE price of $84.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATHEwould be worth at today's price.
$1,000 invested in ATHE on Jul 31, 2025 (≈ 197.628461 ATHE) would be worth
$872.53
-$127.47 (-12.7%) today · 0.87× · US Dollar
Based on a ATHE entry price of $5.06 vs. today's $4.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.54 | $972.47 | -2.8% |
| 1 month ago | $5.46 | $808.61 | -19.1% |
| 3 months ago | $4.73 | $933.4 | -6.7% |
| 6 months ago | $3.11 | $1,419.61 | +42.0% |
| 1 year ago | $5.06 | $872.53 | -12.7% |
| All time (5.0y) ago | $13.8 | $319.93 | -68.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATHE forecast.
Our base-case forecast reaches $8.80 around 2029.
Implied market cap at $8.80: $159.51M
The multi-year forecast shows a bullish trajectory from 2027 onward, with rising average prices and strong upside embedded in the later years.
Key yearly snapshots include: 2027 avg $5.61 (ROI 23.6%), 2028 avg $7.02 (ROI 54.5%), 2029 avg $10.45 (ROI 130.3%), 2030 avg $11.62 (ROI 156.1%), 2031 avg $12.38 (ROI 172.8%), 2032 avg $14.34 (ROI 215.8%), 2033 avg $14.17 (ROI 212.2%), 2034 avg $16.40 (ROI 261.3%), 2035 avg $20.29 (ROI 346.8%), 2040 avg $31.42 (ROI 592%), and 2050 avg $82.56 (ROI 1718.4%). The 2030/2040/2050 forecasts illustrate substantial upside potential, though these are estimates and not guaranteed.
Tap a question to reveal the answer.
2030 avg price $11.62; min $8.14; max $17.99; ROI 156.1; sentiment BULLISH.
Forecasts show bullish sentiment in 2027 onward with rising averages and ROI (e.g., 2027 avg $5.61, ROI 23.6%; 2028 avg $7.02, ROI 54.5%; 2029 avg $10.45, ROI 130.3%; 2030 avg $11.62, ROI 156.1%). However these are estimates and not guaranteed.
The 2050 max forecast is $170.90, which implies the possibility of reaching $100 by 2050.
Current price $4.54; Market cap $82.29M; Rank 4074.
30-day range low $3.58, high $5.76; annualized volatility 70%.
Alterity Therapeutics Limited Community Discussion
0Share your Alterity Therapeutics Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.